Syngenta Q1 Sales Rise to 6.4 Billion on China Growth
Syngenta reported a 2% rise in Q1 sales to $6.4 billion as EBITDA grew 5%. Results were supported by strong growth in China and improved operational efficiency.
Syngenta Group reported Q1 sales rose 2% to $6.4B, driven by expansion in China and efficiency gains. EBITDA for the Switzerland-based firm increased 5% to $1.4B during the first three months of the year. The results signal resilience as the Sinochem-owned company prepares for a planned flotation in Hong Kong.
Syngenta, which competes with CORTEVA INC in the United States, attributed the profit growth to higher-margin new products. The company also faces competition from Germany-based BASF SE and BAYER AG-REG. Efficiency improvements helped offset a market environment defined by geopolitical uncertainty and trade disruption.
